Standout Papers

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation 2011 2026 2016 2021 6.5k
  1. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (2011)
    Manesh R. Patel, Kenneth W. Mahaffey et al. New England Journal of Medicine
  2. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment (2011)
    Keith A.A. Fox, Jonathan P. Piccini et al. European Heart Journal
  3. Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007 (2012)
    Jonathan P. Piccini, Bradley G. Hammill et al. Circulation Cardiovascular Quality and Outcomes
  4. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation (2019)
    Daniel B. Mark, Kevin J. Anstrom et al. JAMA
  5. Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes (2016)
    Benjamin A. Steinberg, Peter Shrader et al. Journal of the American College of Cardiology
  6. Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) (2014)
    Jonathan L. Halperin, Graeme J. Hankey et al. Circulation
  7. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation (2015)
    Emily C. O’Brien, DaJuanicia N. Simon et al. European Heart Journal
  8. Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure (2021)
    Douglas L. Packer, Jonathan P. Piccini et al. Circulation
  9. Atrial Fibrillation and Diabetes Mellitus (2019)
    Allen Wang, Jennifer B. Green et al. Journal of the American College of Cardiology
  10. Heart Failure and Atrial Fibrillation, Like Fire and Fury (2019)
    Matthew A. Carlisle, Marat Fudim et al. JACC Heart Failure
  11. Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control (2018)
    Mikhael F. El‐Chami, Faisal Al-Samadi et al. Heart Rhythm
  12. Postoperative atrial fibrillation: from mechanisms to treatment (2023)
    Mario Gaudino, Antonino Di Franco et al. European Heart Journal
  13. Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry (2024)
    Mikhael F. El‐Chami, Christophe Garweg et al. European Heart Journal

Immediate Impact

132 standout
Sub-graph 1 of 13

Citing Papers

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
2025 Standout
A Dual-Chamber Leadless Pacemaker
2023 Standout
12 intermediate papers

Works of Jonathan P. Piccini being referenced

Atrioventricular Synchronous Pacing Using a Leadless Ventricular Pacemaker
2019
Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control
2018 Standout
and 13 more

Author Peers

Author Last Decade Papers Cites
Jonathan P. Piccini 23179 6791 1777 2838 539 25.2k
Deirdre A. Lane 21425 6619 1348 4173 307 24.6k
Jeff S. Healey 16408 2334 1686 1709 381 17.9k
Stefan H. Hohnloser 28323 3957 2723 2045 417 30.6k
Günter Breithardt 22307 5035 1984 2354 410 24.5k
Basil S. Lewis 18835 6722 6079 2732 274 24.4k
Renato D. Lópes 14286 3940 4467 2164 594 20.5k
Paulus Kirchhof 22251 3170 2220 1952 536 25.1k
Jonathan L. Halperin 28140 9327 3136 5980 296 33.9k
Brian F. Gage 9533 3453 1811 2172 177 17.0k
Freek W.A. Verheugt 14451 4061 3955 1684 273 17.4k

All Works

Loading papers...

Rankless by CCL
2026